Jeannette Guerrasio
Hospitalist · Aurora, CONPI 1083648679
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.3% of the total across 290 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 13.1% — the pattern of someone who eats at a lot of different presentations. Among hospitalist clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 290 payments — averaging $17.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$674
- Novo Nordisk$580
- Amgen$453
- AstraZeneca$336
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$330
- Johnson & Johnson$229
- plus $3K from 32 others
What the payments were for
- Food & beverage$5,04698%
- Education$872%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$5,132 in reported general payments places this provider in the 95th percentile of 547 hospitalist providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 19 | $26,006 |
| CreonLipase/Protease/Amylase | 23 | $25,302 |
| OzempicSemaglutide | 18 | $21,004 |
| XareltoRivaroxaban | 19 | $18,200 |
| GemtesaVibegron | 14 | $9,145 |
| DayvigoLemborexant | 11 | $7,473 |
| SynthroidLevothyroxine Sodium | 53 | $4,089 |
| PaxlovidNirmatrelvir/Ritonavir | 13 | $2,858 |
| Rosuvastatin Calcium | 114 | $1,569 |
| Estradiol | 21 | $1,396 |
| Atorvastatin Calcium | 109 | $1,193 |
| Levothyroxine Sodium | 114 | $1,117 |
| Escitalopram Oxalate | 54 | $1,047 |
| Ventolin HfaAlbuterol Sulfate | 11 | $983 |
| Valsartan | 32 | $937 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCreon, Synthroid | $674 | $29,39176 claims |
| PfizerEliquis, Paxlovid | $81 | $28,86432 claims |
| Novo NordiskOzempic | $580 | $21,00418 claims |
| Johnson & JohnsonXarelto | $229 | $18,20019 claims |
| Eisai Inc.Dayvigo | $207 | $7,47311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 547 hospitalist providers in Colorado.
Other hospitalist in Aurora
- Tejas PatilAurora$94K
- Michael SolaAurora$11K
- Susan CalcaterraAurora$6K
- Mark BrittanAurora$4K
- Lilia CervantesAurora$3K
- Erin GordonAurora$3K
- Hemali PatelAurora$2K
- Alexander SunAurora$1K
- Benjamin WalkerAurora$1K
- David KlimplAurora$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.